Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

5.9K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

33.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.4K
Stem Cell Culture01:17

Stem Cell Culture

6.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.5K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame Topic

Inconsistent ethics reporting in individual participant data meta-analyses: a call for updating PRISMA and PRISMA-IPD.

BMC medicine·2026
Same author

Ethics and Regulation of Human Brain Organoid Research: Recommendations from the Asia Pacific Neuroethics Working Group.

Asian bioethics review·2026
Same author

Intensive care decision-making, survival and dying well: a mixed methods study with people who have been intensive care patients.

Anaesthesia·2026
Same author

Neural Organoids: How Should We Handle the Possibility of Sentience? - CORRIGENDUM.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same author

The case for primary prevention of obesity in the era of GLP-1 therapies.

The Lancet regional health. Europe·2026
Same author

Would a single centralized ethical review in Europe be feasible for multinational trials in public health emergencies?

European journal of internal medicine·2026

Related Experiment Video

Updated: Mar 27, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K

Biobanking human embryonic stem cell lines: policy, ethics and efficiency.

Søren Holm1,2,3

  • 1Centre for Social Ethics and Policy, School of Law, University of Manchester, Manchester, M13 9PL, UK. soren.holm@manchester.ac.uk.

Monash Bioethics Review
|January 14, 2016
PubMed
Summary

Human embryonic stem cell banks are crucial, but policy discussions often overlook donor interests. Ethical arguments dominate establishment, while efficiency arguments are key for maintenance.

Keywords:
Commercial interestsEmbryoEmbryo donationExploitationGamete donationHuman embryonic stem cellsStem cell banks

More Related Videos

Culture and Maintenance of Human Embryonic Stem Cells
09:36

Culture and Maintenance of Human Embryonic Stem Cells

Published on: December 22, 2009

48.6K
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

32.4K

Related Experiment Videos

Last Updated: Mar 27, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K
Culture and Maintenance of Human Embryonic Stem Cells
09:36

Culture and Maintenance of Human Embryonic Stem Cells

Published on: December 22, 2009

48.6K
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

32.4K

Area of Science:

  • Biomedical Ethics
  • Stem Cell Biology
  • Health Policy

Background:

  • Human embryonic stem cell (hESC) banks are established globally by public and private entities.
  • These banks play a vital role in research and therapeutic applications of hESCs.
  • Policy discussions surrounding hESC banking are critical for their development and sustainability.

Purpose of the Study:

  • To critically analyze arguments used in policy discussions for establishing and maintaining hESC banks.
  • To identify the distinct roles of ethical and efficiency arguments in different phases of banking.
  • To highlight the omission of embryo and gamete donor interests in current policy discourse.

Main Methods:

  • Critical analysis of existing policy documents and academic literature on hESC banking.
  • Comparative examination of arguments used in the establishment versus maintenance phases.
  • Discourse analysis to identify stakeholder representation and omissions.

Main Results:

  • Ethical arguments are more prominent during the establishment phase of hESC banks.
  • 'Efficiency arguments' gain importance in the maintenance phase.
  • Arguments considering the interests of embryo and gamete donors are notably absent in current hESC banking policy discussions.

Conclusions:

  • The current discourse on hESC banking policy is artificially isolated from broader discussions on reproductive materials.
  • The exclusion of donor interests may lead to their concerns being overlooked in policy-making.
  • Integrating donor perspectives is essential for a more comprehensive and equitable policy framework for hESC banking.